# EFAVIRENZ, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
> **NDA213509** · New Drug Application · Sponsor: MYLAN · Approved 2024-03-22
## Drug
- **FDA Application Number:** NDA213509
- **Application type:** New Drug Application
- **Brand name:** EFAVIRENZ, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
- **Generic name:** Efavirenz, Emtricitabine And Tenofovir Alafenamide
- **Active ingredients:** EFAVIRENZ, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** MYLAN
- **First approval:** 2024-03-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213509)
---
*AI Analytics · CC0 1.0*